Zhangzhou Pientzehuang Pharmaceutical Co Ltd (SHG:600436) — Market Cap & Net Worth
Market Cap & Net Worth: Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436)
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (SHG:600436) has a market capitalization of $12.67 Billion (CN¥86.61 Billion) as of May 6, 2026. Listed on the SHG stock exchange, this China-based company holds position #1855 globally and #203 in its home market, demonstrating a 1.15% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhangzhou Pientzehuang Pharmaceutical Co Ltd's stock price CN¥143.55 by its total outstanding shares 603317210 (603.32 Million). Analyse cash efficiency ratio of Zhangzhou Pientzehuang Pharmaceutical Co to see how efficiently the company converts income to cash.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Market Cap History: 2015 to 2026
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $3.90 Billion to $12.67 Billion (14.60% CAGR).
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.76x
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's market cap is 1.76 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.36x
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's market cap is 6.36 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.90 Billion | $1.89 Billion | $466.68 Million | 2.07x | 8.35x |
| 2016 | $3.93 Billion | $2.31 Billion | $536.13 Million | 1.70x | 7.33x |
| 2017 | $5.45 Billion | $3.71 Billion | $807.02 Million | 1.47x | 6.75x |
| 2018 | $7.50 Billion | $4.77 Billion | $1.14 Billion | 1.57x | 6.56x |
| 2019 | $9.55 Billion | $5.72 Billion | $1.37 Billion | 1.67x | 6.95x |
| 2020 | $23.38 Billion | $6.51 Billion | $1.67 Billion | 3.59x | 13.99x |
| 2021 | $38.28 Billion | $8.02 Billion | $2.43 Billion | 4.77x | 15.74x |
| 2022 | $25.36 Billion | $8.69 Billion | $2.47 Billion | 2.92x | 10.26x |
| 2023 | $21.36 Billion | $10.06 Billion | $2.80 Billion | 2.12x | 7.64x |
| 2024 | $18.94 Billion | $10.79 Billion | $2.98 Billion | 1.76x | 6.36x |
Competitor Companies of 600436 by Market Capitalization
Companies near Zhangzhou Pientzehuang Pharmaceutical Co Ltd in the global market cap rankings as of May 6, 2026.
Key companies related to Zhangzhou Pientzehuang Pharmaceutical Co Ltd by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #16 globally with a market cap of $885.06 Billion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #17 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #23 globally with a market cap of $543.42 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #37 globally with a market cap of $364.44 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #16 | Eli Lilly and Company | NYSE:LLY | $885.06 Billion | $988.87 |
| #17 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #23 | Johnson & Johnson | NYSE:JNJ | $543.42 Billion | $225.55 |
| #37 | AbbVie Inc | NYSE:ABBV | $364.44 Billion | $206.11 |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Zhangzhou Pientzehuang Pharmaceutical Co Ltd's market cap moved from $3.90 Billion to $ 12.67 Billion, with a yearly change of 14.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥12.67 Billion | -14.95% |
| 2025 | CN¥14.90 Billion | -21.31% |
| 2024 | CN¥18.94 Billion | -11.36% |
| 2023 | CN¥21.36 Billion | -15.74% |
| 2022 | CN¥25.36 Billion | -33.77% |
| 2021 | CN¥38.28 Billion | +63.76% |
| 2020 | CN¥23.38 Billion | +144.68% |
| 2019 | CN¥9.55 Billion | +27.46% |
| 2018 | CN¥7.50 Billion | +37.63% |
| 2017 | CN¥5.45 Billion | +38.68% |
| 2016 | CN¥3.93 Billion | +0.75% |
| 2015 | CN¥3.90 Billion | -- |
End of Day Market Cap According to Different Sources
On May 6th, 2026 the market cap of Zhangzhou Pientzehuang Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.67 Billion USD |
| MoneyControl | $12.67 Billion USD |
| MarketWatch | $12.67 Billion USD |
| marketcap.company | $12.67 Billion USD |
| Reuters | $12.67 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Zhangzhou Pientzehuang Pharmaceutical., Ltd, together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. It offers Chinese medicines in various forms, including capsules, tablets, pills, syrups, and ointments, as well as health care food and functional drinks, special efficacy cosmetics, and household chemicals under the Pien Tze Huang … Read more